Fluoro2 Therapeutics
PrivateCompany Overview
Fluoro2 Therapeutics operates in Healthcare & Life Sciences and is based in Boca Raton, Florida. It was founded in 2014.
Fluoro2 Therapeutics is a biotechnology company developing a perfluorocarbon nanoemulsion designed as an artificial blood substitute for use in trauma, hemorrhage, and other medical situations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fluoro2 Therapeutics Comparables
Compare Fluoro2 Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KaloCyte, Inc. | 84% | |
| VirTech Bio | 84% | |
| HbO2 Therapeutics | 84% |
For institutional investors. Book with your work email.
Fluoro2 Therapeutics Funding Rounds
Historical fundraising activity
Fluoro2 Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fluoro2 Therapeutics's valuation, stock price, and market status.
Is Fluoro2 Therapeutics a public or private company?
Fluoro2 Therapeutics is a private company.
What is the current stock price of Fluoro2 Therapeutics?
Fluoro2 Therapeutics is a private company, so its shares have no public market price. Caplight tracks Fluoro2 Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fluoro2 Therapeutics worth (valuation)?
Valuation information for Fluoro2 Therapeutics is not publicly available.
Can I buy Fluoro2 Therapeutics stock?
Fluoro2 Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fluoro2 Therapeutics's last funding round?
Funding round information for Fluoro2 Therapeutics is not publicly available.
Who are the main investors in Fluoro2 Therapeutics?
Investor information for Fluoro2 Therapeutics is not publicly disclosed.
Will Fluoro2 Therapeutics IPO soon?
No public IPO plans have been announced for Fluoro2 Therapeutics.
How can I track Fluoro2 Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Fluoro2 Therapeutics's shares on secondary markets.